
Opinion|Videos|April 23, 2025
Off Fluctuations in Parkinson Disease
Panelists discuss how off fluctuations in Parkinson disease become increasingly prevalent as the disease progresses, significantly impacting patient quality of life through reduced mobility, independence, and overall well-being.
Advertisement
Episodes in this series

Now Playing
Video content above is prompted by the following:
Prevalence of Off Fluctuations and Quality-of-Life Impact
Off Fluctuations Prevalence:
- Approximately 40% of patients experience motor fluctuations after 4 to 6 years of levodopa therapy
- By 10 years of treatment, up to 90% of patients develop off episodes (Aradi 2020)
- Off periods increase in frequency and duration as disease progresses
- Early fluctuations may be end-of-dose wearing off, progressing to unpredictable on-off phenomena
Quality-of-Life Impact:
- Progressive deterioration in activities of daily living and independence
- Increased caregiver burden and health care utilization
- Significant psychological impact: anxiety, depression, social isolation
- Mobility limitations affecting employment, social interactions, and self-care
- Sleep disturbances and fatigue compound functional limitations
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Current Treatment Strategies for Dravet Syndrome
2
NeurologyLive®'s Conference Coverage, Oveporexton Displays Symptom Improvement in NT1, FDA Allows BLA for AMT-130 in HD
3
Beyond Motor Symptoms: The Power of Connection in Parkinson Disease
4
FDA Allows AMT-130 Huntington Disease Data to Support Planned BLA Submission Under Accelerated Approval Pathway
5















